Sage lays off half of R&D team, shakes up C-suite again
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
Sanofi inks $326M radiopharma deal with Orano
Novartis loses latest bid to block generic version of blockbuster heart drug
Kezar to discontinue mid-stage trial for lupus treatment
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*